David Carroll - Dec 31, 2021 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
SVP, CFO and Treasurer
Signature
/s/ Todd Anderman, as Attorney-in-Fact for David F. Carroll
Stock symbol
ISEE
Transactions as of
Dec 31, 2021
Transactions value $
-$259,310
Form type
4
Date filed
1/4/2022, 04:08 PM
Previous filing
Dec 23, 2021
Next filing
Mar 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise +32.5K +66.57% 81.3K Dec 31, 2021 Direct F1
transaction ISEE Common Stock Sale -$259K -15.8K -19.45% $16.39 65.5K Jan 3, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -32.5K -100% $0.00* 0 Dec 31, 2021 Common Stock 32.5K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 31, 2021.
F3 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.77 to $16.77 on January 3, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees.
F4 On December 9, 2019, the Reporting Person was granted 65,000 restricted stock units, which vest with respect to 50% of the shares subject to the award on December 31, 2020 and with respect to the remaining 50% of the shares subject to the award on December 31, 2021, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.